New high-resolution ultrasound improves prostate cancer diagnosis

A significant breakthrough in prostate cancer diagnostics is emerging through high-resolution micro-ultrasound (microUS) technology.

Operating at 29 MHz—nearly triple the frequency of conventional ultrasound—this system provides microscopic detail, allowing clinicians to visualize subtle structural variations previously invisible.

According to the OPTIMUM trial, micro-ultrasound-guided biopsies are as effective as traditional MRI-guided methods.

The shift toward this technology offers a "one-stop" diagnostic workflow, where patients can undergo imaging and biopsy during a single office visit.

Beyond efficiency, the lower cost and increased availability of ultrasound scanners compared to expensive MRI machines mean that high-quality diagnostic care could become more accessible, particularly in underserved regions.

By combining high-fidelity visual guidance with standardized grading protocols like PRI-MUS, this technology is improving diagnostic precision.

As AI and focal therapy applications advance, micro-ultrasound is poised to transform patient-centered care, providing faster, more accurate results while minimizing the anxiety associated with traditional diagnostic paths.